In other studies, it was shown that a vaccine prepared by the transfer of a cDNA expression library, derived from tumor cells, into a mouse fibroblast cell line engineered to secrete IL-2 appears to be efficacious in the treatment of a brain tumor. This evidence concerns the gene IL2 and brain neoplasm.